Literature DB >> 19029092

Sumoylation regulates the transcriptional activity of MafA in pancreatic beta cells.

Chunli Shao1, Melanie H Cobb.   

Abstract

MafA is a transcriptional regulator expressed primarily in pancreatic beta cells. It binds to the RIPE3b/C1-binding site within the ins gene promoter, which plays a critical role in regulating ins gene expression in response to glucose. Here, we show that MafA is post-translationally modified by the small ubiquitin-related modifiers SUMO-1 and -2. Mutation of a single site in MafA, Lys(32), blocks its sumoylation in beta cells. Incubation of beta cells in low glucose (2 mm) or exposure to hydrogen peroxide increases sumoylation of endogenous MafA. Forced sumoylation of MafA results in reduced transcriptional activity toward the ins gene promoter and increased suppression of the CHOP-10 gene promoter. Sumoylation of MafA has no apparent effect on either its nuclear localization in beta cells or its ubiquitin-dependent degradation. This study suggests that modification of MafA by SUMO modulates gene transcription and thereby beta cell function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19029092      PMCID: PMC2631948          DOI: 10.1074/jbc.M806286200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  ERK1/2-dependent activation of transcription factors required for acute and chronic effects of glucose on the insulin gene promoter.

Authors:  Michael C Lawrence; Kathleen McGlynn; Byung-Hyun Park; Melanie H Cobb
Journal:  J Biol Chem       Date:  2005-05-16       Impact factor: 5.157

Review 2.  Something about SUMO inhibits transcription.

Authors:  Grace Gill
Journal:  Curr Opin Genet Dev       Date:  2005-10       Impact factor: 5.578

Review 3.  Modification of proteins by ubiquitin and ubiquitin-like proteins.

Authors:  Oliver Kerscher; Rachael Felberbaum; Mark Hochstrasser
Journal:  Annu Rev Cell Dev Biol       Date:  2006       Impact factor: 13.827

4.  GSK-3-mediated phosphorylation enhances Maf-transforming activity.

Authors:  Nathalie Rocques; Nancy Abou Zeid; Karine Sii-Felice; Laure Lecoin; Marie-Paule Felder-Schmittbuhl; Alain Eychène; Celio Pouponnot
Journal:  Mol Cell       Date:  2007-11-30       Impact factor: 17.970

Review 5.  Concepts in sumoylation: a decade on.

Authors:  Ruth Geiss-Friedlander; Frauke Melchior
Journal:  Nat Rev Mol Cell Biol       Date:  2007-12       Impact factor: 94.444

Review 6.  Genetics of type 2 diabetes mellitus.

Authors:  Maciej T Malecki
Journal:  Diabetes Res Clin Pract       Date:  2005-03-19       Impact factor: 5.602

7.  Oxidative stress-mediated, post-translational loss of MafA protein as a contributing mechanism to loss of insulin gene expression in glucotoxic beta cells.

Authors:  Jamie S Harmon; Roland Stein; R Paul Robertson
Journal:  J Biol Chem       Date:  2005-01-20       Impact factor: 5.157

8.  Palmitate inhibits insulin gene expression by altering PDX-1 nuclear localization and reducing MafA expression in isolated rat islets of Langerhans.

Authors:  Derek K Hagman; Lori B Hays; Susan D Parazzoli; Vincent Poitout
Journal:  J Biol Chem       Date:  2005-06-08       Impact factor: 5.157

9.  FoxA2, Nkx2.2, and PDX-1 regulate islet beta-cell-specific mafA expression through conserved sequences located between base pairs -8118 and -7750 upstream from the transcription start site.

Authors:  Jeffrey C Raum; Kevin Gerrish; Isabella Artner; Eva Henderson; Min Guo; Lori Sussel; Jonathan C Schisler; Christopher B Newgard; Roland Stein
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

Review 10.  Integration and diversity of the regulatory network composed of Maf and CNC families of transcription factors.

Authors:  Hozumi Motohashi; Tania O'Connor; Fumiki Katsuoka; James Douglas Engel; Masayuki Yamamoto
Journal:  Gene       Date:  2002-07-10       Impact factor: 3.688

View more
  17 in total

1.  Inactivation of specific β cell transcription factors in type 2 diabetes.

Authors:  Shuangli Guo; Chunhua Dai; Min Guo; Brandon Taylor; Jamie S Harmon; Maike Sander; R Paul Robertson; Alvin C Powers; Roland Stein
Journal:  J Clin Invest       Date:  2013-07-01       Impact factor: 14.808

2.  Phosphorylation within the MafA N terminus regulates C-terminal dimerization and DNA binding.

Authors:  Shuangli Guo; Nathan L Vanderford; Roland Stein
Journal:  J Biol Chem       Date:  2010-03-05       Impact factor: 5.157

Review 3.  Sumoylation modulates oxidative stress relevant to the viability and functionality of pancreatic beta cells.

Authors:  Ping Yang; Shuang Hu; Fei Yang; Xiang-Qian Guan; Shi-Qiang Wang; Ping Zhu; Fei Xiong; Shu Zhang; Junfa Xu; Qi-Lin Yu; Cong-Yi Wang
Journal:  Am J Transl Res       Date:  2014-07-18       Impact factor: 4.060

4.  Regulation of CCAAT/enhancer-binding protein homologous protein (CHOP) expression by interleukin-1 beta in pancreatic beta cells.

Authors:  Chunli Shao; Michael C Lawrence; Melanie H Cobb
Journal:  J Biol Chem       Date:  2010-04-27       Impact factor: 5.157

5.  SUMOylation protects against IL-1β-induced apoptosis in INS-1 832/13 cells and human islets.

Authors:  Catherine Hajmrle; Mourad Ferdaoussi; Gregory Plummer; Aliya F Spigelman; Krista Lai; Jocelyn E Manning Fox; Patrick E MacDonald
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-19       Impact factor: 4.310

6.  SUMO downregulates GLP-1-stimulated cAMP generation and insulin secretion.

Authors:  Sindhu Rajan; Jacqueline Torres; Michael S Thompson; Louis H Philipson
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-01-10       Impact factor: 4.310

7.  Sumoylation of bZIP transcription factor NRL modulates target gene expression during photoreceptor differentiation.

Authors:  Jerome E Roger; Jacob Nellissery; Douglas S Kim; Anand Swaroop
Journal:  J Biol Chem       Date:  2010-06-15       Impact factor: 5.157

Review 8.  Posttranslational modifications in diabetes: Mechanisms and functions.

Authors:  Bin Chen; Jianing Zhong; Ang Hu; Haohong Zou
Journal:  Rev Endocr Metab Disord       Date:  2022-06-13       Impact factor: 9.306

9.  SUMOylation regulates insulin exocytosis downstream of secretory granule docking in rodents and humans.

Authors:  Xiao-Qing Dai; Greg Plummer; Marina Casimir; Youhou Kang; Catherine Hajmrle; Herbert Y Gaisano; Jocelyn E Manning Fox; Patrick E MacDonald
Journal:  Diabetes       Date:  2011-01-24       Impact factor: 9.461

10.  Degradation of cAMP-responsive element-binding protein by the ubiquitin-proteasome pathway contributes to glucotoxicity in beta-cells and human pancreatic islets.

Authors:  Safia Costes; Brigitte Vandewalle; Cécile Tourrel-Cuzin; Christophe Broca; Nathalie Linck; Gyslaine Bertrand; Julie Kerr-Conte; Bernard Portha; François Pattou; Joel Bockaert; Stéphane Dalle
Journal:  Diabetes       Date:  2009-02-17       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.